C60 Fullerene

Supplement

C60 Fullerene is retained as a catalog identity with independently verified primary-literature context. No qualified exposure model, dose recommendation, efficacy claim, or safety claim is provided.

Pharmacokinetic model

A route-level PK model for c60 fullerene is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.

Key facts

Category: Supplement
Suggested cadence: once daily

Research behind this entry

Biochemical and hematologic effects of polyvinylpyrrolidone-wrapped fullerene C60 after oral administration. Yamashita K, Yoshioka Y, Pan H, Taira M, Ogura T, Nagano T, Aoyama M, Nagano K, Abe Y, Kamada H, Tsunoda SI, Aoshima H, Nabeshi H, Yoshikawa T, Tsutsumi Y · Die Pharmazie, 2013
This citation reports an animal study involving C60 Fullerene. It does not establish a qualified human dose, safety profile, efficacy claim, or pharmacokinetic route for this catalog record.

1 published study referenced in the app, each with a plain-language summary.